ProMedix Overview
- Year Founded
-
2019

- Status
-
Private
- Employees
-
5

- Latest Deal Type
-
Mezzanine
- Latest Deal Amount
-
$200K
- Investors
-
13
ProMedix General Information
Description
Developer of medical devices designed to improve home patient monitoring. The company's devices aid in the diagnostic evaluation as well as monitoring of therapeutic interventions for multiple medical conditions including trauma, dehydration, and sepsis, enabling physicians to simplify home and critical care, prevent unnecessary acute visits, and improve emergency or critical care.
Contact Information
Website
www.promedixinc.comCorporate Office
- 4640 Southwest Macadam Avenue
- Suite 200
- Portland, OR 97239
- United States
Corporate Office
- 4640 Southwest Macadam Avenue
- Suite 200
- Portland, OR 97239
- United States
ProMedix Timeline
ProMedix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
14. Mezzanine | 12-Dec-2024 | $200K | Completed | Generating Revenue | ||
13. Grant | 23-Oct-2024 | Completed | Generating Revenue | |||
12. Accelerator/Incubator | Completed | Generating Revenue | ||||
11. Early Stage VC | 08-Sep-2023 | Completed | Generating Revenue | |||
10. Early Stage VC | 13-Jun-2023 | Completed | Generating Revenue | |||
9. Grant | 15-Feb-2023 | Completed | Generating Revenue | |||
8. Early Stage VC | 31-Oct-2022 | Completed | Generating Revenue | |||
7. Early Stage VC | 01-Mar-2022 | Completed | Generating Revenue | |||
6. Accelerator/Incubator | 01-Jan-2022 | $280K | Completed | Generating Revenue | ||
5. Accelerator/Incubator | 10-Nov-2021 | $180K | $280K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ProMedix Patents
ProMedix Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230355122-A1 | Systems and methods for measuring capillary refill time | Active | 11-Mar-2022 | ||
US-20230363659-A1 | Systems and methods for measuring capillary refill time | Pending | 11-Mar-2022 | ||
US-20230337925-A1 | Systems and methods for measuring capillary refill time | Pending | 11-Mar-2022 | ||
US-12226198-B2 | Systems and methods for measuring capillary refill time | Active | 11-Mar-2022 | ||
US-20210369124-A1 | Measuring capillary refill time | Active | 29-May-2020 | A61B5/02028 |
ProMedix Signals
ProMedix Investors (13)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Bend Venture Conference | Other | |||
Oregon Entrepreneurs Network | Accelerator/Incubator | Minority | ||
Oregon Nanoscience and Microtechnologies Institute | University | Minority | ||
National Science Foundation | Government | |||
Elevate Capital | Venture Capital | Minority |
ProMedix FAQs
-
When was ProMedix founded?
ProMedix was founded in 2019.
-
Where is ProMedix headquartered?
ProMedix is headquartered in Portland, OR.
-
What is the size of ProMedix?
ProMedix has 5 total employees.
-
What industry is ProMedix in?
ProMedix’s primary industry is Monitoring Equipment.
-
Is ProMedix a private or public company?
ProMedix is a Private company.
-
What is ProMedix’s current revenue?
The current revenue for ProMedix is
. -
How much funding has ProMedix raised over time?
ProMedix has raised $1.26M.
-
Who are ProMedix’s investors?
Bend Venture Conference, Oregon Entrepreneurs Network, Oregon Nanoscience and Microtechnologies Institute, National Science Foundation, and Elevate Capital are 5 of 13 investors who have invested in ProMedix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »